Palmitoyl Dipeptide-5 Diaminohydroxybutyrate
Palmitoyl Dipeptide-5 Diaminohydroxybutyrate is the product of the reaction of palmitic acid and diaminohydroxybutyric acid with Dipeptide-5
Limited Data
Insufficient safety data available. Consider enriching this ingredient.
Details
Description
Palmitoyl Dipeptide-5 Diaminohydroxybutyrate is the product of the reaction of palmitic acid and diaminohydroxybutyric acid with Dipeptide-5
Purpose
Function
Skin Conditioning
Profile
Properties
Silicone
Silicone free
Compliance
Regulatory Status
EU
Permitted
Safety
GOOD
US
Permitted
Absorptionlow
Sensitizationlow
MoSnot established
ConcernLow
Verdict
CAS 794590-34-4. EU: Permitted (CosIng INCI inventory); not listed in Annexes II-VI of EC 1223/2009. US: Not prohibited by FDA; no CIR individual monograph; covered under palmitoyl oligopeptides class review. Trade name: SYN-TACKS (DSM-Firmenich).
US Note
Not restricted by FDA. Used in OTC anti-aging formulations targeting the dermal-epidermal junction (DEJ). Part of SYN-TACKS peptide complex by DSM-Firmenich. No safety concerns at typical 0.5-2% use.
Assessment
Ratings
Reference
Identifiers
No registry identifiers available for this ingredient.